Serotonin, disease and the future

Works Cited

  • Aghajanian, G., & Sanders-Bush, E. (2001, Nov 2). Serotonin. Neuropsychopharmacology—5th Generation of Progress, 20.
  • Bennett, A., Lesch, K., Heils, A., Long, J., Lorenz, J., Shoaf, S., et al. (2002). Early experience and serotonin transporter gene variation interact to influence primate CNS function. Molecular psychiatry, 7 (1), 118-122.
  • Boal, M. (2004, March). Blood, sweat and serotonin: the master chemist of the psychedelic movement and his 40-year battle with the government. Retrieved January 1, 2009.
  • Brown, G., & Harris, T. (2008). Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction. Journal of affective disorders, 111 (1), 1-12.
  • Charlton, B. G. (1998). Psychopharmacology and the human condition. Journal of the Royal Society of Medicine, 599-601.
  • Drago, A., Ronchi, D., & Serretti, A. (2008). 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), 11 (5), 701-21.
  • Fantegrossi, W., Murnane, K., & Reissig, C. (2008). The behavioral pharmacology of hallucinogens. Biochemical pharmacology, 75 (1), 17-33.
  • Gonda, X., Fountoulakis, K., Juhasz, G., Rihmer, Z., Lazary, J., Laszik, A., et al. (2008, Sep 19). Association of the s allele of the 5-HTTLPR with neuroticism-related traits and temperaments in a psychiatrically healthy population. European archives of psychiatry and clinical neuroscience.
  • Heurteaux, C., Lucas, G., Guy, N., El Yacoubi, M., Thümmler, S., Peng, X.-D., et al. (2006). Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nature neuroscience,  9 (9), 1134-41.
  • Jonnakuty, C., & Gragnoli, C. (2008). What do we know about serotonin? Journal of cellular physiology, 217 (2), 301-6.
  • Kirsch, I., Deacon, B., Huedo-Medina, T., Scoboria, A., Moore, T., & Johnson, B. (2008). Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration. PLoS Medicine, 5 (2), e45.
  • Knutson, W. O. (1998). Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry, (155), 373-379.
  • Kramer, P. D. (1993). Listening to Prozac. London: Fourth Estate.
  • Le François, B., Czesak, M., Steubl, D., & Albert, P. (2008). Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology, 55 (6), 977-85.
  • Lesch, K., & Gutknecht, L. (2005). Pharmacogenetics of the serotonin transporter. Progress in neuro-psychopharmacology & biological psychiatry, 29 (6), 1062-73.
  • Marazziti, D., Akiskal, H., Rossi, A., & Cassano, G. (1999). Alteration of the platelet serotonin transporter in romantic love. Psychological medicine, 29 (3), 741-5.
  • Mathew, S. e. (2002, Jan 1). Cerebrospinal ?uid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions. Stress.
  • Nakamura, M., Ueno, S., Sano, A., & Tanabe, H. (2000). The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Molecular psychiatry, 5 (1), 32-8.
  • Pearce, D. (2008). Mental Health in the Third Millennium: MDMA and Beyond. Retrieved Jan 1, 2009.
  • Serretti, A., Drago, A., & De Ronchi, D. (2007). HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Current medicinal chemistry, 14 (19), 2053-69.
  • Serretti, A., Mandelli, L., Giegling, I., Schneider, B., Hartmann, A., Schnabel, A., et al. (2007). HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. American journal of medical genetics Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics, 144B (3), 291-9.
  • Turner, A. (2008, May). Ecstasy is the key to treating PTSD. The Times.
  • Turner, E., Matthews, A., Linardatos, E., Tell, R., & Rosenthal, R. (2008). Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy. The New England Journal of Medicine, 358 (3), 252.
  • Wendland, J., Martin, B., Kruse, M., Lesch, K.-P., & Murphy, D. (2006). Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Molecular psychiatry, 11 (3), 224-22.

Pages: 1 2 3 4